関連する実験動画

Updated: Jan 13, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

800

乳癌における標的腋窩郭清：現在のエビデンスと進行中の試験

Francesco Loi1, Elie Rassy2, Thomas Grinda1

  • 1Department of Cancer Medicine, Gustave Roussy, University Paris-Saclay, Villejuif, France.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
|January 10, 2026
PubMed
まとめ

術後化学療法後のリンパ節陽性乳癌患者において、標的腋窩郭清（TAD）は有望視されている。このアプローチは、腋窩リンパ節郭清（ALND）の必要性を減らし、患者の罹患を回避できる可能性がある。

キーワード:
腋窩手術乳癌偽陰性率術後化学療法センチネルリンパ節標的腋窩郭清

さらに関連する動画

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

4.0K
Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models13:43

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models

Published on: April 1, 2022

4.9K

関連する概念動画

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K